Investigation of Therapeutic and Protective Action of Reaferon-ES Lipint® on Mice Infected with Avian Influenza Virus (Subtype H5N1) by O. K. Demina, A. A. Sergeev, A. P. Agafonov, A. N. Shikov, A. O. Sementsova, AL. A. Sergeev, A. N. Sergeev, I. G. Drozdov

Get full text

Investigation of Susceptibility of Influenza Viruses A (H1N1), the Cause of Infection in Humans in April - May 2009, to Antivirals in MDCK Cell Culture by A. A. Romanovskaya, A. M. Durymanov, K. A. Sharsov, A. V. Zaikovskaya, I. M. Susloparov, A. M. Shestopalov, I. A. Leneva, I. G. Drozdov

Get full text

In vitro Efficacy of Ingavirin® against the Pandemic Influenza Virus A(H1N1/09)v by L. N. Shishkina, V. E. Nebolsin, A. S. Kabanov, M. O. Skarnovich, U. B. Erdyneeva, N. A. Mazurkova, O. A. Serova, E. A. Stavsky, I. G. Drozdov

Get full text

In vivo Efficacy of Ingavirin® Against Pandemic A(H1N1/09)v Influenza Virus by L. N. Shishkina, V. E. Nebolsin, M. O. Skarnovich, A. S. Kabanov, A. A. Sergeev, U. B. Erdyneeva, O. A. Serova, O. K. Demina, A. P. Agafonov, E. A. Stavsky, I. G. Drozdov

Get full text